Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renato Delascio Lopes

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Heart Rhythm|August 2, 2025
Apixaban for stroke prevention in subclinical atrial fibrillation detected by an implantable cardiac monitor: A subgroup analysis of ARTESiALucas Yixi Xing, Renato Delascio Lopes, William Finlay McIntyre, et al.
BMC Cardiovascular Disorders|October 1, 2025
Prevalence and factors associated with cardiometabolic multimorbidity: a cross-sectional study in older adults of the first Brazilian hypertension registrySandro Rogério Rodrigues Batista, Leandro Ferreira Martins, Priscila Valverde Vitorino de Oliveira, et al.
American Heart Journal|July 31, 2020
Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trialRodrigo Bruno Biagioni, Renato Delascio Lopes, Leandro Barile Agati, et al.
Global Heart|July 14, 2025
Blood Pressure Control and Anthropometric Differences in Afro-Descendants and Other Ethnic Groups in Hypertensive Brazilian PopulationsMaicon Borges Euzébio, Priscila Valverde de Oliveira Vitorino, Andréa Araújo Brandão, et al.
Arquivos Brasileiros De Cardiologia|December 17, 2020
Evaluation of 1-Year Follow-up of Patients Included in the Registry of Clinical Practice in Patients at High Cardiovascular Risk (REACT)Pedro Gabriel Melo de Barros E Silva, Otavio Berwanger, Dalton Bertolim Precoma, et al.
Arquivos Brasileiros De Cardiologia|July 28, 2021
Accuracy of Post-thrombolysis ST-segment Reduction as an Adequate Reperfusion Predictor in the Pharmaco-Invasive ApproachHenrique Tria Bianco, Rui Povoa, Maria Cristina Izar, et al.
BMC Cardiovascular Disorders|June 15, 2023
Metrics of care and cardiovascular outcomes in patients with ST-elevation myocardial infarction treated with pharmacoinvasive strategy: a decade-long network in a populous city in BrazilPedro Ivo De Marqui Moraes, Attilio Galhardo, Adriano Henrique Pereira Barbosa, et al.
Revista Brasileira De Terapia Intensiva|October 14, 2020
COVID-19-associated ARDS treated with DEXamethasone (CoDEX): study design and rationale for a randomized trialBruno Martins Tomazini, Israel Silva Maia, Flavia Regina Bueno, et al.
Revista Brasileira De Terapia Intensiva|September 23, 2020
Rationale and design of the "Tocilizumab in patients with moderate to severe COVID-19: an open-label multicentre randomized controlled" trial (TOCIBRAS)Danielle Leão Cordeiro de Farias, João Prats, Alexandre Biasi Cavalcanti, et al.
Revista Da Sociedade Brasileira De Medicina Tropical|April 19, 2023
Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors)Lívia Pimenta Bonifácio, Eduardo Ramacciotti, Leandro Barile Agati, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Heart Rhythm|August 2, 2025
Apixaban for stroke prevention in subclinical atrial fibrillation detected by an implantable cardiac monitor: A subgroup analysis of ARTESiALucas Yixi Xing, Renato Delascio Lopes, William Finlay McIntyre, et al.
BMC Cardiovascular Disorders|October 1, 2025
Prevalence and factors associated with cardiometabolic multimorbidity: a cross-sectional study in older adults of the first Brazilian hypertension registrySandro Rogério Rodrigues Batista, Leandro Ferreira Martins, Priscila Valverde Vitorino de Oliveira, et al.
American Heart Journal|July 31, 2020
Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trialRodrigo Bruno Biagioni, Renato Delascio Lopes, Leandro Barile Agati, et al.
Global Heart|July 14, 2025
Blood Pressure Control and Anthropometric Differences in Afro-Descendants and Other Ethnic Groups in Hypertensive Brazilian PopulationsMaicon Borges Euzébio, Priscila Valverde de Oliveira Vitorino, Andréa Araújo Brandão, et al.
Arquivos Brasileiros De Cardiologia|December 17, 2020
Evaluation of 1-Year Follow-up of Patients Included in the Registry of Clinical Practice in Patients at High Cardiovascular Risk (REACT)Pedro Gabriel Melo de Barros E Silva, Otavio Berwanger, Dalton Bertolim Precoma, et al.
Arquivos Brasileiros De Cardiologia|July 28, 2021
Accuracy of Post-thrombolysis ST-segment Reduction as an Adequate Reperfusion Predictor in the Pharmaco-Invasive ApproachHenrique Tria Bianco, Rui Povoa, Maria Cristina Izar, et al.
BMC Cardiovascular Disorders|June 15, 2023
Metrics of care and cardiovascular outcomes in patients with ST-elevation myocardial infarction treated with pharmacoinvasive strategy: a decade-long network in a populous city in BrazilPedro Ivo De Marqui Moraes, Attilio Galhardo, Adriano Henrique Pereira Barbosa, et al.
Revista Brasileira De Terapia Intensiva|October 14, 2020
COVID-19-associated ARDS treated with DEXamethasone (CoDEX): study design and rationale for a randomized trialBruno Martins Tomazini, Israel Silva Maia, Flavia Regina Bueno, et al.
Revista Brasileira De Terapia Intensiva|September 23, 2020
Rationale and design of the "Tocilizumab in patients with moderate to severe COVID-19: an open-label multicentre randomized controlled" trial (TOCIBRAS)Danielle Leão Cordeiro de Farias, João Prats, Alexandre Biasi Cavalcanti, et al.
Revista Da Sociedade Brasileira De Medicina Tropical|April 19, 2023
Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors)Lívia Pimenta Bonifácio, Eduardo Ramacciotti, Leandro Barile Agati, et al.
Pageof 7